Brief: Amneal Reports Third Quarter 2024 Financial Results
Nov 8 (Reuters) - Amneal Pharmaceuticals Inc AMRX.O :
* AMNEAL REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS
* AMNEAL PHARMA: AFFIRMS 2024 FULL YEAR GUIDANCE
* AMNEAL PHARMA: Q3 ADJUSTED EPS $0.16
* AMNEAL PHARMA: Q3 NET REVENUE $702 MILLION
* Q3 EARNINGS PER SHARE VIEW $0.14, REVENUE VIEW $696.8
MILLION --
LSEG IBES DATA
Source text: ID:nBw8F6t9ha
Further company coverage: AMRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Amneal Pharmaceuticals
See all newsUS RESEARCH ROUNDUP-3M Company, Constellation Energy, Metropolitan Bank Holding
US FDA is working with manufacturers to boost estrogen patch supply amid access concerns (updated)
U.S. RESEARCH ROUNDUP- Intuit, MongoDB, Zscaler
U.S. STOCKS ON THE MOVE-Mastercard, Yum, Equinix
Amneal Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary